Welcome to our dedicated page for HLTY news (Ticker: HLTY), a resource for investors and traders seeking the latest updates and insights on HLTY stock.
PreCheck Health Services Inc. (HLTY) delivers innovative medical diagnostics through its FDA-cleared PC8B screening device. This dedicated news hub provides investors and healthcare professionals with essential updates on regulatory milestones, product developments, and strategic partnerships.
Access official press releases covering device certifications, clinical collaborations, and educational initiatives like genetic testing webinars. Our curated collection ensures transparent tracking of HLTY's progress in precision medicine and diagnostic technology.
Discover updates categorized for efficient navigation: regulatory filings, operational expansions, and clinical research advancements. Bookmark this page for real-time access to verified information about HLTY's patented screening solutions and their impact on modern healthcare.
PreCheck Health Services and St. Jude Lab are hosting a webinar titled 'Advancing Care Through Revolutionary Genetic Testing' on April 4, 2024. This event aims to inform healthcare providers about the latest advancements in genetic testing, focusing on areas such as cancer predisposition, immunodeficiency, endocrinology, thyroid disease, and neurology. Key speakers include Heather Wetzel of DNAvisit, Sonia Dawhan of St. Jude Lab, Francis Pittilloni of PreCheck Health Services, and Amhed El-kaliny of DNAvisit. The webinar aims to improve patient care and operational efficiency through education on the appropriate use of genetic tests.
